Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Why AbbVie was not Impacted by Amgen Humira Biosimilar Submission
Bidness, ETC
Mon, 11/30/15 - 09:27 am
Tags:
AbbVie, Humira, Amgen, biosimilars, ABP 501
Amgen applies to FDA for competitor drug to AbbVie's Humira
Marketwatch
Wed, 11/25/15 - 06:43 pm
Tags:
Amgen, FDA, AbbVie, Humira, biosimilars, psoriasis
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
Motley Fool
Wed, 11/25/15 - 01:20 pm
Tags:
JNJ, FDA, Amgen, Darzalex, daratumumab, Multiple Myeloma
CVS Chooses Repatha as New Cholesterol Drug for Caremark
WSJ Online
Mon, 11/23/15 - 09:35 am
Tags:
CVS Caremark, Amgen, Repatha, Sanofi, Regeneron, Praluent
Biogen and Samsung's Enbrel biosimilar wins EMA nod for EU approval
Fierce Pharma
Fri, 11/20/15 - 06:21 pm
Tags:
Biogen, Samsung, Enbrel, biosimilars, Europe, Pfizer, Amgen, anti-TNF
Big pharma trying to quash CA drug price cap effort with massive campaign war chest
BioPharma Dive
Fri, 11/20/15 - 10:55 am
Tags:
California, drug pricing, JNJ, AbbVie, Amgen, Eli Lilly, Bristol-Myers Squibb
Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis
Seeking Alpha
Thu, 11/19/15 - 04:39 pm
Tags:
Amgen, Regeneron, Medicines Company, Isis Pharmaceuticals, Gilead Sciences, Biogen
Amgen's Repatha gets a thumbs-down from U.K. cost-effectiveness watchdogs
Fierce Pharma
Wed, 11/18/15 - 10:15 pm
Tags:
Amgen, Repatha, NICE, UK, PCSK9 inhibitors
Is Allergan-Amgen Merger Possible?
Bidness, ETC
Wed, 11/18/15 - 09:55 am
Tags:
Allergan, Amgen, M&A, Pfizer
Novartis biosimilar takes aim at Amgen drug Neulasta
Yahoo/Reuters
Wed, 11/18/15 - 09:30 am
Tags:
Novartis, Amgen, biosimilars, Neulasta, Sandoz
Novartis, Roche CEOs see performance-based future, but U.S. isn't ready yet
Fierce Biotech
Fri, 11/13/15 - 10:00 am
Tags:
Novartis, Roche, Pharma CEOs, Amgen, Repatha, Joe Jimenez, Severin Schwan
Why Amgen, Inc Should Acquire Alnylam
Bidness, ETC
Thu, 11/12/15 - 09:25 am
Tags:
Amgen, Alnylam, M&A, ALN-PCSsc, Medicines Company
Amgen's Humira biosimilar clears Phase III and joins a crowd of contenders
Fierce Biotech
Wed, 11/11/15 - 10:04 am
Tags:
Amgen, Humira, biosimilars, rheumatoid arthritis
Big Pharma's Shoes Don't Fit Amgen
Bloomberg
Tue, 11/10/15 - 09:38 am
Tags:
Amgen, Big Pharma
What Companies Amgen May Be Eyeing For M&A?
Bidness, ETC
Tue, 11/10/15 - 08:29 am
Tags:
Amgen, M&A, Seattle Genetics, Alnylam, Dr Reddy's
Cytokinetics, Amgen drug shows promise in heart failure study
Yahoo/Reuters
Mon, 11/9/15 - 10:28 am
Tags:
Amgen, Cytokinetics, omecamtiv, chronic heart failure
Amgen’s Late-Stage Pipeline Continues to Advance in 3Q15
Yahoo/Market Realist
Wed, 11/4/15 - 02:06 pm
Tags:
Amgen
Amgen’s Oncology Drugs Register Solid Growth In 3Q15
Yahoo/Market Realist
Tue, 11/3/15 - 02:18 pm
Tags:
Amgen, earnings
Drugmaker Amgen posts big increases in 3Q profit, sales
Yahoo/AP
Wed, 10/28/15 - 06:19 pm
Tags:
Amgen, earnings
Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Forbes
Wed, 10/28/15 - 09:17 am
Tags:
Amgen, Imlygic, T-Vec, blood cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.